Anterix Q1 EPS $(0.11) Beats $(0.58) Estimate, Sales $608.00K Miss $1.18M Estimate
Portfolio Pulse from Benzinga Newsdesk
Anterix (NASDAQ:ATEX) reported Q1 EPS of $(0.11), beating the analyst consensus estimate of $(0.58) by 81.03%. However, the company's quarterly sales of $608.00K missed the analyst consensus estimate of $1.18M by 48.47%. This represents an 84.51% increase in EPS and an 81.49% increase in sales compared to the same period last year.
August 04, 2023 | 11:01 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Anterix's Q1 EPS beat estimates by 81.03% but sales missed estimates by 48.47%. This could lead to mixed reactions in the market.
Anterix's Q1 results show a significant beat on EPS estimates, which is a positive signal. However, the company missed sales estimates, which could be a concern for investors. The mixed results could lead to uncertainty in the market, potentially causing neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100